
Get Cash Back and $0 Commissions
+ The Power of TradeStation
PRNewswire 12-May-2026 4:05 PM
In-house e-commerce transition and new CEO expected to support scalable recurring revenue growth strategy
SURPRISE, Ariz., May 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products today announced financial results for the first quarter ended March 31, 2026 and provided an update on the Company's acceleration of revenue under newly appointed Chief Executive Officer, Michael Edell.
Q1 2026 Financial Highlights
April 2026 E-Commerce Momentum
Recent Operational and Strategic Highlights
Management Commentary
"SenesTech is entering a new phase where we are building a more scalable, data-driven and recurring revenue business model around the growing demand for non-poison rodent management solutions," said Michael Edell, Chief Executive Officer of SenesTech. "The strategic transition to directly managing our Amazon business and revamping our online e-commerce store has significantly improved our visibility into customer behavior, advertising performance, subscriptions, and overall channel economics. We are already seeing strong momentum in our direct-to-consumer business, particularly through accelerating subscription adoption and improved Amazon execution."
Mr. Edell continued, "Our efforts across Amazon, Shopify, packaging redesign, digital media buying, subscriptions, and customer engagement are all connected initiatives intended to reduce friction, improve conversion, increase customer retention, and create a stronger recurring revenue foundation. At the same time, we remain focused on improving operational discipline, maintaining strong gross margins and positioning the Company for scalable long-term growth."
"Our first quarter results reflected the expected temporary disruption associated with transitioning Amazon operations in-house, however the underlying consumer demand trends and April proof points were highly encouraging," said Tom Chesterman, Chief Financial Officer of SenesTech. "Direct-to-consumer revenue increased 42% to a record $194,000 during Q1, gross margin expanded to a Company record 68.6%, and subscription-based sales continued to accelerate breaking past revenue numbers. We believe these trends support the long-term strategic value of directly controlling our e-commerce channels and building a more predictable recurring revenue mix."
Use of Non-GAAP Measure
Adjusted EBITDA and Adjusted Net Loss are non-GAAP measures. However, these measures are not intended to be a substitute for those financial measures reported in accordance with GAAP. These measures have been included because management believes that, when considered together with the GAAP figures, they provide meaningful information related to operating performance and liquidity trends. We use these non-GAAP financial measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors concerning our financial performance. These adjustments may be calculated by us differently than other companies that disclose measures with the same or similar term. See our attached financials for a reconciliation of the non-GAAP measures to the nearest GAAP measure.
Conference Call Details
Date: Tuesday, May 12, 2026.
Time: 5:00 p.m. ET.
Webcast: https://app.webinar.net/m976bqQblKE.
Webcast Replay: Available for 90 days on the Company's website.
About SenesTech
SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company's groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.
For more information visit https://senestech.com/.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, statements regarding the acceleration of the Company's direct-to-consumer and e-commerce initiatives, the recurring nature of the Company's growing director-to-consumer business model, any growth attributable to the appointment of the Company's new CEO, the Company's efforts in driving B2B revenues, any increases in conversion rates and subscription growth, and any international expansion opportunities for the Company.
Forward-looking statements may describe future expectations, plans, results, or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; regulatory approval and regulation of our products; challenges transitioning to direct management of Amazon sales of Evolve products or the results of such direct management not being as expected; having to use cash at times and in ways other than as planned; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
CONTACT:
Investors: Robert Blum, Lytham Partners, LLC, (602) 889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., (928) 779-4143
SENESTECH, INC. | |||
BALANCE SHEETS | |||
(In thousands, except share and per share data) | |||
(Unaudited) | |||
March 31, | December 31, | ||
ASSETS | |||
Current assets: | |||
Cash and cash equivalents | $ 6,804 | $ 7,575 | |
Short-term investments | — | 994 | |
Accounts receivable, net | 163 | 201 | |
Inventory | 1,048 | 994 | |
Prepaid expenses and other current assets | 338 | 297 | |
Total current assets | 8,353 | 10,061 | |
Right to use asset, operating lease | 2,295 | 2,336 | |
Property and equipment, net | 379 | 410 | |
Other noncurrent assets | 36 | 36 | |
Total assets | $ 11,063 | $ 12,843 | |
LIABILITIES AND STOCKHOLDERS' EQUITY | |||
Current liabilities: | |||
Accounts payable | $ 115 | $ 183 | |
Accrued expenses | 593 | 383 | |
Current portion of operating lease liability | 142 | 139 | |
Current portion of notes payable | 63 | 61 | |
Deferred revenue | 25 | 32 | |
Total current liabilities | 938 | 798 | |
Operating lease liability, less current portion | 2,296 | 2,332 | |
Notes payable, less current portion | 128 | 145 | |
Total liabilities | 3,362 | 3,275 | |
Stockholders' equity: | |||
Common stock | 5 | 5 | |
Additional paid-in capital | 152,239 | 152,043 | |
Accumulated deficit | (144,543) | (142,480) | |
Total stockholders' equity | 7,701 | 9,568 | |
Total liabilities and stockholders' equity | $ 11,063 | $ 12,843 | |
SENESTECH, INC. | |||
STATEMENTS OF OPERATIONS | |||
(In thousands, except share and per share data) | |||
(Unaudited) | |||
Three Months Ended | |||
2026 | 2025 | ||
Revenues, net | $ 493 | $ 485 | |
Cost of sales | 155 | 172 | |
Gross profit | 338 | 313 | |
Operating expenses: | |||
Research and development | 422 | 418 | |
Selling, general and administrative | 2,035 | 1,558 | |
Total operating expenses | 2,457 | 1,976 | |
Loss from operations | (2,119) | (1,663) | |
Interest income (expense), net | 56 | (2) | |
Net loss | $ (2,063) | $ (1,665) | |
Weighted average shares outstanding — basic and diluted | 5,263,717 | 1,299,971 | |
Loss per share — basic and diluted | $ (0.39) | $ (1.28) | |
SENESTECH, INC. | |||
Itemized Reconciliation Between Net Loss and Adjusted EBITDA (non-GAAP) | |||
(In thousands) | |||
(Unaudited) | |||
Three Months Ended | |||
2026 | 2025 | ||
Net loss (as reported, GAAP) | $ (2,063) | $ (1,665) | |
Non-GAAP adjustments: | |||
Severance costs | 230 | 27 | |
One-time legal costs | 213 | 45 | |
Interest income, net | (56) | 2 | |
Stock-based compensation expense | 23 | 91 | |
Depreciation expense | 31 | 39 | |
Non-cash operating lease expense | 8 | — | |
Total non-GAAP adjustments | 449 | 204 | |
Adjusted EBITDA loss (non-GAAP) | $ (1,614) | $ (1,461) | |
SenesTech Inc. | |||||
Reconciliation of Net Loss and Adjusted Net Loss (non-GAAP) | |||||
(In thousands) | |||||
(Unaudited) | |||||
Three Months Ended | Percent | ||||
2026 | 2025 | ||||
Net loss (as reported, GAAP) | $ (2,063) | $ (1,665) | 24 % | ||
Non-GAAP adjustments: | |||||
Severance costs | 230 | 27 | |||
One-time legal costs | 213 | 45 | |||
Adjusted net loss (non-GAAP) | $ (1,620) | $ (1,593) | 2 % | ||
View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-reports-record-direct-to-consumer-and-subscription-growth-following-strategic-e-commerce-transition-302769942.html
SOURCE SenesTech, Inc.